a drugmaker named novo nordisk is a 200 grand a year charter member in gingrich's center for health transformationin addition to that, novo, which is the world's largest maker of insulin, hired a related gingrich company, the gingrich group. the "times" reports that a presentation made by a gingrich aide to novo executives in 2004 emphasized the gingrich center was "working to insure" that medicare covered insulin made by novo. the "times" further citing for this presentation the claim that mr. gingrich himself planned to meet with members of congress, "to help them develop priorities," on fighting diabetes. then there's this from the "times" story. in its annual report to shareholders, this is a quote, "novo nordisk listed its work with mr. gingrich under the category of public policy activities, noting such activities are often referred to as lobbying." a spokesman for novo nordisk backed away from that term saying speaker gingrich was simply providing guidance and strategic advice on "how best we could inform policy makers." in the end, novo nordisk won the diabetes issue. also in the end gingr

a drugmaker named novo nordisk is a 200 grand a year charter member in gingrich's center for health transformationto that, novo, which is the world's largest maker of insulin, hired a related gingrich company, the gingrich group. the "times" reports that a presentation made by a gingrich aide to novo executives in 2004 emphasized the gingrich center was "working to insure" that medicare covered insulin made by novo. the "times" further citing for this presentation the claim that mr. gingrich himself planned to meet with members of congress, "to help them develop priorities," on fighting diabetes. then there's this from the "times" story. in its annual report to shareholders, this is a quote, "novo nordisk listed its work with mr. gingrich under the category of public policy activities, noting such activities are often referred to as lobbying." a spokesman for novo nordisk backed away from that term saying speaker gingrich was simply providing guidance and strategic advice on "how best we could inform policy makers." in the end, novo nordisk won the diabetes issue. also in the end gingrich's client